How well does the PCA3–incorporated chun nomogram perform in predicting prostate biopsy outcome among South African men?
| dc.contributor.author | Adam, Ahmed | |
| dc.contributor.author | Manda, S.O.M. (Samuel) | |
| dc.date.accessioned | 2013-05-30T06:34:25Z | |
| dc.date.available | 2013-05-30T06:34:25Z | |
| dc.date.issued | 2013-06 | |
| dc.description.abstract | The incidence of prostate cancer among South African men is just as significant as it is worldwide [1,2]. Although the role of the prostate cancer antigen 3 (PCA3) assay in predicting biopsy outcome has proven beneficial in a South African context [3], the assessment of its role incorporated into a prostate cancer risk calculator has not yet been explored on the continent of Africa. We aimed to assess the performance of the PCA3-incorporated Chun nomogram [4] and to compare its performance with other contemporary risk calculators. | en_US |
| dc.description.librarian | hb2013 | en_US |
| dc.description.uri | http://www.europeanurology.com/article/S0302-2838(13)00139-5 | en_US |
| dc.identifier.citation | Adam, A & Manda, SO 2013, 'How well does the PCA3–incorporated chun nomogram perform in predicting prostate biopsy outcome among South African men?', European Urology, vol. 63, no. 6, pp. e67-e86. | en_US |
| dc.identifier.issn | 0302-2838 (print) | |
| dc.identifier.issn | 1421-993x (online) | |
| dc.identifier.other | 10.1016/j.eururo.2013.02.027 | |
| dc.identifier.uri | http://hdl.handle.net/2263/21574 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.rights | © 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved. | en_US |
| dc.subject | Prostate cancer | en_US |
| dc.subject | South African men | en_US |
| dc.subject | PCA3–incorporated Chun Nomogram | en_US |
| dc.title | How well does the PCA3–incorporated chun nomogram perform in predicting prostate biopsy outcome among South African men? | en_US |
| dc.type | Postprint Article | en_US |